vs
Side-by-side financial comparison of チャブ (CB) and eHealth, Inc. (EHTH), based on the latest 10-Q / 10-K filings. Click either name above to swap in a different company.
チャブ is the larger business by last-quarter revenue ($15.1B vs $326.2M, roughly 46.2× eHealth, Inc.). eHealth, Inc. runs the higher net margin — 21.3% vs 26.7%, a 5.4% gap on every dollar of revenue. On growth, チャブ posted the faster year-over-year revenue change (6.3% vs 3.5%). Over the past eight quarters, eHealth, Inc.'s revenue compounded faster (87.3% CAGR vs 8.1%).
チャブ・リミテッドはスイス・チューリッヒに登記された米瑞系保険会社で、ニューヨーク証券取引所に上場しS&P500の構成銘柄である。世界最大の上場損害保険会社として各種保険商品を提供し、55か国・地域及びロンドンのロイズ保険市場で事業を展開している。
eHealth, Inc.はeHealthInsuranceとして事業を展開する上場企業で、健康保険を扱うオンラインマーケットプレイスです。デラウェア州で法人登記し、本社はカリフォルニア州サンタクララに置かれています。メディケア関連の処方薬プラン、メディギャップ、メディケアアドバンテージプランを主力に個人向け健康保険も販売しており、米国全50州とワシトンD.C.で事業を展開しています。
CB vs EHTH — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $15.1B | $326.2M |
| Net Profit | $3.2B | $87.2M |
| Gross Margin | — | 55.3% |
| Operating Margin | 25.0% | 38.7% |
| Net Margin | 21.3% | 26.7% |
| Revenue YoY | 6.3% | 3.5% |
| Net Profit YoY | 24.7% | -10.6% |
| EPS (diluted) | $8.05 | $2.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align — see 8-quarter trend below.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history — bar widths are scaled to the larger of the two companies so you can eyeball the size gap and growth trajectory without doing math. Quarters aligned by calendar period (report date) so offset fiscal years line up.
| Q4 25 | $15.1B | $326.2M | ||
| Q3 25 | $16.1B | $53.9M | ||
| Q2 25 | $14.8B | $60.8M | ||
| Q1 25 | $13.4B | $113.1M | ||
| Q4 24 | $14.2B | $315.2M | ||
| Q3 24 | $14.8B | $58.4M | ||
| Q2 24 | $13.8B | $65.9M | ||
| Q1 24 | $12.9B | $93.0M |
| Q4 25 | $3.2B | $87.2M | ||
| Q3 25 | $2.8B | $-31.7M | ||
| Q2 25 | $3.0B | $-17.4M | ||
| Q1 25 | $1.3B | $1.9M | ||
| Q4 24 | $2.6B | $97.5M | ||
| Q3 24 | $2.3B | $-42.5M | ||
| Q2 24 | $2.2B | $-28.0M | ||
| Q1 24 | $2.1B | $-17.0M |
| Q4 25 | — | 55.3% | ||
| Q3 25 | — | -0.3% | ||
| Q2 25 | — | 31.1% | ||
| Q1 25 | — | 36.9% | ||
| Q4 24 | — | 52.0% | ||
| Q3 24 | — | -6.5% | ||
| Q2 24 | — | 28.7% | ||
| Q1 24 | — | 31.7% |
| Q4 25 | 25.0% | 38.7% | ||
| Q3 25 | 24.1% | -77.1% | ||
| Q2 25 | 25.0% | -37.9% | ||
| Q1 25 | 12.5% | 4.2% | ||
| Q4 24 | 22.0% | 35.7% | ||
| Q3 24 | 20.2% | -74.0% | ||
| Q2 24 | 19.6% | -42.5% | ||
| Q1 24 | 20.4% | -19.3% |
| Q4 25 | 21.3% | 26.7% | ||
| Q3 25 | 17.3% | -58.8% | ||
| Q2 25 | 20.0% | -28.6% | ||
| Q1 25 | 10.0% | 1.7% | ||
| Q4 24 | 18.2% | 30.9% | ||
| Q3 24 | 15.7% | -72.7% | ||
| Q2 24 | 16.1% | -42.5% | ||
| Q1 24 | 16.6% | -18.3% |
| Q4 25 | $8.05 | $2.43 | ||
| Q3 25 | $6.99 | $-1.46 | ||
| Q2 25 | $7.35 | $-0.98 | ||
| Q1 25 | $3.29 | $-0.33 | ||
| Q4 24 | $6.31 | $2.93 | ||
| Q3 24 | $5.70 | $-1.83 | ||
| Q2 24 | $5.46 | $-1.33 | ||
| Q1 24 | $5.23 | $-0.96 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest filing — the kind of financial-strength check premium terminals charge for.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $73.7M |
| Total DebtLower is stronger | $15.7B | — |
| Stockholders' EquityBook value | $73.8B | $591.6M |
| Total Assets | $272.3B | $1.3B |
| Debt / EquityLower = less leverage | 0.21× | — |
8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.
| Q4 25 | — | $73.7M | ||
| Q3 25 | — | $63.1M | ||
| Q2 25 | — | $65.9M | ||
| Q1 25 | — | $121.1M | ||
| Q4 24 | — | $39.2M | ||
| Q3 24 | — | $64.0M | ||
| Q2 24 | — | $126.3M | ||
| Q1 24 | — | $175.0M |
| Q4 25 | $15.7B | — | ||
| Q3 25 | $15.7B | — | ||
| Q2 25 | $13.5B | — | ||
| Q1 25 | $14.5B | — | ||
| Q4 24 | $14.4B | — | ||
| Q3 24 | $14.6B | — | ||
| Q2 24 | $13.2B | — | ||
| Q1 24 | $13.2B | — |
| Q4 25 | $73.8B | $591.6M | ||
| Q3 25 | $71.9B | $514.2M | ||
| Q2 25 | $69.4B | $554.9M | ||
| Q1 25 | $65.7B | $581.6M | ||
| Q4 24 | $64.0B | $588.4M | ||
| Q3 24 | $65.8B | $499.3M | ||
| Q2 24 | $61.0B | $548.9M | ||
| Q1 24 | $60.5B | $582.8M |
| Q4 25 | $272.3B | $1.3B | ||
| Q3 25 | $270.2B | $1.0B | ||
| Q2 25 | $261.6B | $1.1B | ||
| Q1 25 | $251.8B | $1.1B | ||
| Q4 24 | $246.5B | $1.2B | ||
| Q3 24 | $250.6B | $1.0B | ||
| Q2 24 | $238.6B | $1.0B | ||
| Q1 24 | $234.9B | $1.1B |
| Q4 25 | 0.21× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.19× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.22× | — | ||
| Q3 24 | 0.22× | — | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | 0.22× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Net income can be massaged; cash flow is harder to fake.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.1B | $-35.9M |
| Free Cash FlowOCF − Capex | — | $-36.1M |
| FCF MarginFCF / Revenue | — | -11.1% |
| Capex IntensityCapex / Revenue; lower = less reinvestment burden | — | 0.0% |
| Cash ConversionOCF / Net Profit; >1× = earnings back up with cash | 1.26× | -0.41× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-27.6M |
8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.
| Q4 25 | $4.1B | $-35.9M | ||
| Q3 25 | $3.6B | $-25.3M | ||
| Q2 25 | $3.6B | $-41.2M | ||
| Q1 25 | $1.6B | $77.1M | ||
| Q4 24 | $4.6B | $-27.7M | ||
| Q3 24 | $4.3B | $-29.3M | ||
| Q2 24 | $4.1B | $-32.2M | ||
| Q1 24 | $3.2B | $70.8M |
| Q4 25 | — | $-36.1M | ||
| Q3 25 | — | $-25.5M | ||
| Q2 25 | — | $-42.8M | ||
| Q1 25 | — | $76.8M | ||
| Q4 24 | — | $-28.3M | ||
| Q3 24 | — | $-30.3M | ||
| Q2 24 | — | $-32.4M | ||
| Q1 24 | — | $70.6M |
| Q4 25 | — | -11.1% | ||
| Q3 25 | — | -47.4% | ||
| Q2 25 | — | -70.4% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | -9.0% | ||
| Q3 24 | — | -51.8% | ||
| Q2 24 | — | -49.3% | ||
| Q1 24 | — | 75.9% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.2% |
| Q4 25 | 1.26× | -0.41× | ||
| Q3 25 | 1.30× | — | ||
| Q2 25 | 1.20× | — | ||
| Q1 25 | 1.18× | 39.55× | ||
| Q4 24 | 1.77× | -0.28× | ||
| Q3 24 | 1.86× | — | ||
| Q2 24 | 1.83× | — | ||
| Q1 24 | 1.50× | — |
Financial Flow Comparison
Sankey diagram of revenue → gross profit → operating profit → net profit for each company. Charts shown full-width and stacked so both segment hierarchies are readable side-by-side on desktop and mobile.
Revenue Breakdown by Segment
CB
Segment breakdown not available.
EHTH
| Medicare | $282.7M | 87% |
| Other | $29.2M | 9% |
| Ancillaries | $7.9M | 2% |
| Commission Members Approved In Prior Periods | $3.8M | 1% |
| Small Business | $3.1M | 1% |
| Commission Revenue From Renewals | $2.4M | 1% |
